<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>The Eurofever/PRINTO classification criteria for hereditary recurrent fevers and their performance</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">The Eurofever/PRINTO classification criteria for hereditary recurrent fevers and their performance</h1>
<div class="graphic"><div class="figure"><div class="ttl">The Eurofever/PRINTO classification criteria for hereditary recurrent fevers and their performance</div><div class="cntnt"><table cellspacing="0"><colgroup span="4" width="25%"></colgroup> <tbody> <tr> <td class="subtitle1">Cryopyrin-associated periodic syndromes</td> <td class="subtitle1">Familial Mediterranean fever</td> <td class="subtitle1">Tumor necrosis factor receptor-associated periodic fever syndrome</td> <td class="subtitle1">Mevalonate kinase deficiency</td> </tr> <tr class="divider_bottom"> <td>Presence of a <strong>confirmatory <em>NLRP3</em> genotype</strong>* and <strong>at least 1</strong> among the following: <ul class="decimal_heading"> <li>Urticarial rash </li> <li>Red eye (conjunctivitis, episcleritis, uveitis) </li> <li>Neurosensorial hearing loss </li> </ul> <p>OR</p> Presence of a <strong>not confirmatory <em>NLRP3</em> genotype<sup>¶</sup></strong> and <strong>at least 2</strong> among the following: <ul class="decimal_heading"> <li>Urticarial rash </li> <li>Red eye (conjunctivitis, episcleritis, uveitis) </li> <li>Neurosensorial hearing loss </li> </ul> </td> <td>Presence of a <strong>confirmatory <em>MEFV</em> genotype</strong>* and <strong>at least 1</strong> among the following: <ul class="decimal_heading"> <li>Duration of episodes 1 to 3 days </li> <li>Arthritis </li> <li>Chest pain </li> <li>Abdominal pain </li> </ul> <p>OR</p> Presence of a <strong>not confirmatory <em>MEFV</em> genotype</strong><sup>Δ</sup> and <strong>at least 2</strong> among the following: <ul class="decimal_heading"> <li>Duration of episodes 1 to 3 days </li> <li>Arthritis </li> <li>Chest pain </li> <li>Abdominal pain </li> </ul> </td> <td>Presence of a <strong>confirmatory <em>TNFRSF1A</em> genotype</strong>* and <strong>at least 1</strong> among the following: <ul class="decimal_heading"> <li>Duration of episodes ≥7 days </li> <li>Myalgia </li> <li>Migratory rash </li> <li>Periorbital oedema </li> <li>Relatives affected </li> </ul> <p>OR</p> Presence of a <strong>not confirmatory <em>TNFRSF1A</em> genotype</strong><sup>¶</sup> and <strong>at least 2</strong> among the following: <ul class="decimal_heading"> <li>Duration of episodes ≥7 days </li> <li>Myalgia </li> <li>Migratory rash </li> <li>Periorbital oedema </li> <li>Relatives affected </li> </ul> </td> <td>Presence of a confirmatory <em><strong>MVK</strong></em><strong> genotype</strong>* and <strong>at least 1</strong> among the following: <ul class="decimal_heading"> <li>Gastrointestinal symptoms </li> <li>Cervical lymphadenitis </li> <li>Aphthous stomatitis </li> </ul> </td> </tr> <tr class="divider_bottom"> <td>Sensitivity: 1</td> <td>Sensitivity: 0.94</td> <td>Sensitivity: 0.95</td> <td>Sensitivity: 0.98</td> </tr> <tr class="divider_bottom"> <td>Specificity: 1</td> <td>Specificity: 0.95</td> <td>Specificity: 0.99</td> <td>Specificity: 1</td> </tr> <tr> <td>Accuracy: 1</td> <td>Accuracy: 0.98</td> <td>Accuracy: 0.99</td> <td>Accuracy: 1</td> </tr> </tbody></table></div><div class="graphic_lgnd">A patient with evidence of elevation of acute phase reactants (ESR, CRP, or SAA) in correspondence to the clinical flares and careful consideration of possible confounding diseases (neoplasms, infections, autoimmune conditions, other inborn errors of immunity) and a reasonable period of recurrent disease activity (at least 6 months) is classified as having hereditary recurrent fever if the criteria are met.</div><div class="graphic_footnotes">PRINTO: Paediatric Rheumatology International Trials Organisation; <em>NLRP3</em>: NLR family pyrin domain-containing 3; <em>MEFV</em>: MEFV innate immunity regulator, pyrin; <em>TNFRSF1A</em>: TNF receptor superfamily member 1A; <em>MVK</em>: mevalonate kinase; ESR: erythrocyte sedimentation rate; CRP: C-reactive protein; SAA: serum amyloid A.<br/>* Pathogenic or likely pathogenic variants (heterozygous in autosomal-dominant diseases; homozygous or in trans [or biallelic] compound heterozygous in autosomal-recessive diseases).<br/>¶ Variant of uncertain significance (VUS). Benign and likely benign variants should be excluded.<br/>Δ In trans compound heterozygous for one pathogenic <em>MEFV</em> variants and one VUS, or biallelic VUS, or heterozygous for one pathogenic <em>MEFV</em> variant.</div><div class="graphic_reference">Reproduced with permission from: Gattorno M, Hofer M, Federici S, et al. Classification criteria for autoinflammatory recurrent fevers. Ann Rheum Dis 2019; 78(8):1025-1032. Copyright © 2019 BMJ Publishing Group Ltd.</div><div id="graphicVersion">Graphic 101819 Version 5.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
